Sucampo Pharmaceuticals (SCMP)

Add to Watchlists Create an Alert
9.02 +0.17  +1.92%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Sucampo Pharmaceuticals Cash and ST Investments:

58.06M for Dec. 31, 2012
View Full Chart

Sucampo Pharmaceuticals Cash and ST Investments Chart

    Sucampo Pharmaceuticals Historical Cash and ST Investments Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 58.06M
    Sept. 30, 2012 63.48M
    June 30, 2012 71.38M
    March 31, 2012 75.17M
    Dec. 31, 2011 75.11M
    Sept. 30, 2011 85.98M
    June 30, 2011 94.44M
    March 31, 2011 96.84M
    Dec. 31, 2010 103.77M
    Sept. 30, 2010 99.08M
    June 30, 2010 98.46M
    March 31, 2010 91.82M
    Dec. 31, 2009 133.85M
    Sept. 30, 2009 84.79M
       
    June 30, 2009 110.17M
    March 31, 2009 121.05M
    Dec. 31, 2008 105.31M
    Sept. 30, 2008 106.48M
    June 30, 2008 114.10M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    Dec. 31, 2005 Go Pro

    About Cash and Short Term Investments

    Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

    Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
    Learn More

    Get data for

    SCMP Cash and ST Investments Benchmarks

    Companies
    Orexigen Therapeutics 137.40M
    Synergy Pharmaceuticals 12.42M
    Alexza Pharmaceuticals 11.71M

    SCMP Cash and ST Investments Rankings

    Overall 67th percentile
    2441 of 7600
    Sector 61st percentile
    252 of 653 in Healthcare
    Industry 54th percentile
    30 of 66 in Drug Manufacturers - Specialty & Generic

    SCMP Cash and ST Investments Range, Past 5 Years

    Minimum 58.06M Dec 2012
    Maximum 133.85M Dec 2009
    Average 94.18M